Lifecore Biomedical, Inc. (LNDC) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1156769,
    "name": "Lifecore Biomedical, Inc.",
    "stock_name": "Lifecore Biomedical, Inc.",
    "full_name": "Lifecore Biomedical, Inc.",
    "name_url": "stocks-analysis/lifecore-biomedical-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "7.77",
    "chg": 0.05,
    "chgp": "0.65%",
    "dir": 1,
    "prev_price": "7.72",
    "mcapval": "272.70",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US5147661046",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "230.74 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lifecore-biomedical-inc-1156769-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Lifecore Biomedical, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-lifecore-biomedical-inc-technically-bullish-or-bearish-3545127",
        "imagepath": "",
        "date": "2025-09-20 19:04:19",
        "description": "As of 25 August 2025, the technical trend for Lifecore Biomedical, Inc. has changed from bullish to mildly bullish. The weekly MACD and KST indicators are mildly bearish, while the monthly MACD and KST are bullish. The daily moving averages are bullish, and Bollinger Bands are bullish on both weekly and monthly time frames. However, Dow Theory and OBV indicate a mildly bearish stance on the weekly and monthly charts. \n\nIn terms of performance, the stock has outperformed the S&P 500 over the past week and month, returning 2.06% and 7.16% respectively, but has underperformed over the year-to-date and longer periods. Overall, the current technical stance is mildly bullish, driven by strong daily moving averages and bullish Bollinger Bands, despite some bearish signals on the weekly indicators...."
      },
      {
        "title": "Is Lifecore Biomedical, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-lifecore-biomedical-inc-overvalued-or-undervalued-3541848",
        "imagepath": "",
        "date": "2025-09-20 17:37:52",
        "description": "As of 2 January 2025, Lifecore Biomedical, Inc. has moved from a fair to a risky valuation grade. The company appears to be overvalued given its high Price to Book Value of 5.35 and negative EV to EBIT and EV to EBITDA ratios of -30.78 and -81.49, respectively. Additionally, the company's ROCE stands at -7.31% and ROE at -89.08%, indicating significant financial distress.\n\nIn comparison to its peers, Lifecore Biomedical's EV to EBITDA ratio of -96.8085 is notably worse than scPharmaceuticals, Inc. at -4.6432 and Vanda Pharmaceuticals, Inc. at 0.5601. This suggests that Lifecore is underperforming relative to its industry counterparts. Despite a strong 1-year stock return of 52.50% compared to the S&P 500's 17.14%, the long-term performance over 3 and 5 years shows declines of -17.99% and -20.78%, respectively, reinforcing the notion of overvaluation...."
      }
    ],
    "total": 6,
    "sid": "1156769",
    "stock_news_url": "https://www.marketsmojo.com/news/lifecore-biomedical-inc-1156769"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Lifecore Biomedical, Inc. technically bullish or bearish?

2025-09-20 19:04:19

As of 25 August 2025, the technical trend for Lifecore Biomedical, Inc. has changed from bullish to mildly bullish. The weekly MACD and KST indicators are mildly bearish, while the monthly MACD and KST are bullish. The daily moving averages are bullish, and Bollinger Bands are bullish on both weekly and monthly time frames. However, Dow Theory and OBV indicate a mildly bearish stance on the weekly and monthly charts. In terms of performance, the stock has outperformed the S&P 500 over the past week and month, returning 2.06% and 7.16% respectively, but has underperformed over the year-to-date and longer periods. Overall, the current technical stance is mildly bullish, driven by strong daily moving averages and bullish Bollinger Bands, despite some bearish signals on the weekly indicators....

Is Lifecore Biomedical, Inc. overvalued or undervalued?

2025-09-20 17:37:52

As of 2 January 2025, Lifecore Biomedical, Inc. has moved from a fair to a risky valuation grade. The company appears to be overvalued given its high Price to Book Value of 5.35 and negative EV to EBIT and EV to EBITDA ratios of -30.78 and -81.49, respectively. Additionally, the company's ROCE stands at -7.31% and ROE at -89.08%, indicating significant financial distress. In comparison to its peers, Lifecore Biomedical's EV to EBITDA ratio of -96.8085 is notably worse than scPharmaceuticals, Inc. at -4.6432 and Vanda Pharmaceuticals, Inc. at 0.5601. This suggests that Lifecore is underperforming relative to its industry counterparts. Despite a strong 1-year stock return of 52.50% compared to the S&P 500's 17.14%, the long-term performance over 3 and 5 years shows declines of -17.99% and -20.78%, respectively, reinforcing the notion of overvaluation....

View All News